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Abstract
The N-terminal fragments of mutant huntingtin (mHTT) misfold and assemble into oligomers, which ultimately bundle into
insoluble fibrils. Conformations unique to various assemblies of mHTT remain unknown. Knowledge on the half-life of vari-
ous multimeric structures of mHTT is also scarce. Using a panel of four new antibodies named PHP1–4, we have identified
new conformations in monomers and assembled structures of mHTT. PHP1 and PHP2 bind to epitopes within the proline-rich
domain (PRD), whereas PHP3 and PHP4 interact with motifs formed at the junction of polyglutamine (polyQ) and polyproline
(polyP) repeats of HTT. The PHP1- and PHP2-reactive epitopes are exposed in fibrils of mHTT exon1 (mHTTx1) generated from
recombinant proteins and mHTT assemblies, which progressively accumulate in the nuclei, cell bodies and neuropils in the
brains of HD mouse models. Notably, electron microscopic examination of brain sections of HD mice revealed that PHP1- and
PHP2-reactive mHTT assemblies are present in myelin sheath and in vesicle-like structures. Moreover, PHP1 and PHP2 anti-
bodies block seeding and subsequent fibril assembly of mHTTx1 in vitro and in a cell culture model of HD. PHP3 and PHP4 bind
to epitopes in full-length and N-terminal fragments of monomeric mHTT and binding diminishes as the mHTTx1 assembles
into fibrils. Interestingly, PHP3 and PHP4 also prevent the aggregation of mHTTx1 in vitro highlighting a regulatory function
for the polyQ-polyP motifs. These newly detected conformations may affect fibril assembly, stability and intercellular trans-
port of mHTT.
Introduction
Huntington’s disease (HD) is an inherited neurodegenerative
disorder caused by expansion of a CAG repeat in the exon-1 of
huntingtin gene, which translates into an abnormal polyglut-
amine (polyQ) in huntingtin protein (HTT) (1). Proteolytic proc-
essing of mutant huntingtin (mHTT) ultimately generates
N-terminal fragments such as cleaved products A and B (cpA
and cpB) and exon-1 (here we refer to as mHTTx1), which are
amyloidogenic and assemble into various not well-
characterized structures linked to impaired cell signaling, neu-
roinflammation and neurodegeneration (2,3). cpA is produced
by the enzymatic cleavage of larger N-terminal fragments of
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mHTT by an aspartyl protease generating a peptide of approxi-
mately 115 amino acids (AA). cpB is estimated to be 214 AA and
the pathway regulating its production remains unknown (4).
Aberrant splicing of huntingtin mRNA also produces truncated
transcripts in a CAG-dependent manner, which contribute
to the production of mHTTx1 protein (5). Emerging studies sug-
gest that misfolded N-terminal fragments of mHTT assemblies
may be structurally and functionally diverse. For example,
small soluble oligomers of mHTTx1 induce cellular stress
and toxicity, whereas large bundled insoluble fibrils inhibit
apoptosis but could activate necrotic pathways (6–9). Thus,
neurotoxicity in HD may be triggered by collective damage
induced by various assemblies of mHTT acting in different
neuronal compartments. The notion that the N-terminal frag-
ments of mHTT forms a repertoire of structures with specific bi-
ological and pathological properties in vivo merits further
investigation.
Characterization of a panel of anti-HTT monoclonal antibod-
ies (mAbs) demonstrated that mHTTx1 accumulates in different
subcellular compartments (10). Whether a unique assembly of
mHTTx1 interacts with a specific cellular organelle remains un-
known. It is likely that each assembly of mHTTx1 may acquire
‘signature conformation(s)’, which could be identified by spe-
cific antibodies. Initially, it was predicted that novel and poten-
tially toxic conformations may arise from the expanded polyQ
in HTT. Studies using the polyQ-specific 3B5H10 mAb reported
the formation of a novel epitope linked to mHTT toxicity (11).
However, comparison of three anti-polyQ antibodies MW1,
3B5H10 and 1C2 did not reveal any conformation-dependent
binding. All three antibodies reacted similarly to mHTT but dis-
played lower affinities for the normal HTT (12,13). Thus, the
evolution of novel conformations by the expanded polyQ in
HTT requires further investigation. More recent studies suggest
that the expanded polyQ domain of HTT is static, clusteredand
does not contribute to the heterogeneity of mHTTx1 assemblies
(6,14,15). However, domains flanking the polyQ repeat of mHTT
appear to influence misfolding and neurotoxicity. The N-termi-
nal 17 AA domain (N17) preceding the polyQ, the polyproline
(polyP) repeats and the proline-rich domain (PRD) downstream
of the polyQ have been implicated in the aggregation and toxic-
ity of mHTTx1 in cell and animal models (6,16–19). For example,
the N17 domain of mHTTx1 promotes the formation of bundled
aggregates, whereas the C-terminal polyP repeats including PRD
favor the assembly of unbundled fibrils (6). The N17 domain
also harbors the sites for several post-translational modifica-
tions, which may alter the folding of mHTTx1 (20, 21). The PRD
of mHTT is the most dynamic epitope in the assembled fibrils
and may contribute to misfolding and evolution of new confor-
mations (14,15). The PRD also interacts with various cellular
proteins, which may control the formation of various assem-
blies in vivo (22). Thus, the notion that mHTTx1 aggregates into
an array of structures with potentially distinct functions is gain-
ing momentum and remains an interesting area of investiga-
tion in HD research (6,14,15).
Using a panel of four new mAbs, we have detected novel
conformations formed at the polyQ-polyP junction and within
the PRD of mHTT. The epitopes at the polyQ-polyP are confined
to mHTT monomers, whereas those within the PRD are pre-
dominantly exposed in fibrils, which progressively accumulate
in the brains of HD mouse models, interact with vesicles and
myelin sheath insulating axons and may play a role in neuro-
toxicity and intercellular transport of mHTT.
Results
Binding of PHP1–4 antibodies to mHTTx1 structures
in vitro
We selected four clones from a mAb library based on reactivity
to recombinant mHTTx1 by various assays described below and
labeled as PHP1–4. The isotypes of these antibodies are IgG1j,
IgG2j, IgG1j and IgG1j, respectively. An overlapping peptide ar-
ray spanning the HTTx1 sequence was used to map the binding
of each antibody to its target domain (10). PHP1 and PHP2 react
with the peptide sequence QAQPLLPQP within the PRD of hu-
man HTT, whereas PHP3 and PHP4 recognize novel epitopes
formed by QQQQQQPP AA sequence. The exact number of pro-
line and glutamine repeats required for the binding of PHP3 and
PHP4 is hard to predict, however, proline residues are critical
since no reactivity is observed to polyQ peptides and binding to
peptides with more than two prolines is enhanced
(Supplementary Material, Fig. S1). To our knowledge, this is the
first report on defined antigenic epitopes formed by the PRD and
at the boundary of polyQ and polyP repeats of HTT. Although
PHP1–PHP2 and PHP3–PHP4 show reactivity to similar linear
peptides, all are different clones based on the AA sequence in
the antigen-binding domains of variable heavy (VH) and vari-
able light (VL) of each antibody (data not shown). Thus, we pre-
dict each PHP antibody may recognize a unique antigenic motif
under optimal physiological conditions.
To identify structures that are recognized by PHP antibodies,
we performed dot blot assays with recombinant monomers of
mHTTx1 (46Q) fused to thioredoxin (TRX-mHTTx1) and in vitro-
assembled fibrils that were either bundled or not. The structure
of each assembly was verified by electron microscopy (EM)
(Fig. 1A, leftmost two panels, respectively). We found that PHP1
and PHP2 display high reactivity for unbundled fibrils with sub-
stantially less binding to monomeric TRX-mHTTx1 or bundled
fibrils (Fig.1 B). PHP3 and PHP4 showed only weak reactivity to
monomers and mHTTx1 fibrils suggesting that the antibody-
binding sites are not easily accessible (Fig. 1B). None of the anti-
bodies bound to amyloid beta (Ab) fibrils indicating specificity
for mHTTx1 (Fig. 1A, third panel from left and Fig. 1B). The pep-
tide array data suggested that QAQPLLPQP sequence is impor-
tant for PHP1 and PHP2 interaction (Supplementary Material,
Fig. S1). To further test this notion, we compared the reactivity
of PHP1 and PHP2 to unbundled fibrils of mHTTx1 that either
contain the native sequence or a version in which the PRD was
mutagenized into a continuous stretch of polyP (see Materials
and Methods section). The mutagenized mHTTx1 formed fibrils,
which were verified by EM (Fig. 1A, right-most panel). Negligible
binding was observed for the latter consistent with both anti-
bodies binding to a region in the PRD that does not exclusively
contain proline residues (Fig. 1C).
To further examine the interactions of PHP antibodies with
mHTTx1 assemblies, we used a sensitive immunoassay based
on the SMC Errena immunoassay platform (23). mHTTx1 (46Q)
fused to maltose-binding protein (MBP) remains soluble but
aggregates once MBP is removed. We performed a time-course
fibril assembly experiment initiated by removing MBP from
mHTTx1. Products were captured at different time points by
PHP1 and PHP2 antibodies and detected by MW8, which recog-
nizes an epitope at the C-terminus of mHTTx1 and has an affin-
ity for fibrils (10,24). We found that PHP1 and PHP2 bind to
mHTTx1 structures assembled within 30 min after the cleav-
age of MBP with a peak binding at 6 h post aggregation (Fig. 2A
and B, respectively). The reactivity of PHP1 and PHP2 towards
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mHTTx1 assemblies was confirmed by using PHP1 and PHP2
antibodies for both capturing and detecting fibrils in the SMC
Errena immunoassays. These assays generated profiles very
similar to those observed with MW8 as detection antibody.
Consistent with the dot blot assays (Fig. 1B), weak binding was
detected when soluble MBP-mHTTx1 was used as antigen
(Fig. 2, Supplementary Material, Fig. S2). Previous studies dem-
onstrated that MW8 antibody is reactive to some assembled
structures of mHTTx1 in FRET assays (24). Thus, the binding
sites for MW8, PHP1 and PHP2 mAbs may be exposed on similar
assemblies of mHTTx1 (2,10). PHP1 and PHP2 also captured mis-
folded species of mHTT in the brain lysates of symptomatic het
Q175 HD mice, which express full-length HTT with175Qs (25)
(Supplementary Material, Fig. S3). In similar assays, PHP3 and
PHP4 reacted with monomeric MBP-mHTTx1 fusion protein cap-
tured by 2B7 antibody specific to the N17 domain of HTT (24).
However, binding of PHP3 and PHP4 to soluble mHTTx1 dimin-
ished gradually as fibril assembly proceeded (Fig. 2C and D).
The low binding of PHP3 and PHP4 for assembled structures of
mHTTx1 was further verified by SMC Errena immunoassays
using PHP3 and PHP4 antibodies for capturing and MW8 for
detecting fibrils. The binding of PHP3 and PHP4 to assembled
fibrils was minimal supporting the preference of these mAbs for
soluble mHTTx1 (Supplementary Material, Fig. S4).
PHP1 and PHP2 bind to mHTTx1 fibrils assembled in
HEK-293 cells
We expressed WT (8Q) and various constructs of mHTTx1 (73Q)
(Fig. 3A) in HEK-293 cells and examined the binding of PHP anti-
bodies to monomeric or assemblies by SDS-PAGE western
blotting (WB). PHP1 and PHP2 displayed weak binding to WT
HTTx1 but showed no binding to the monomeric mHTTx1
(Fig. 3B, left two panels, asterisks). Minimal reactivity was also
detected with mHTTx1 lacking the N17 domain (DN) (Fig. 3B, left
two panels, arrows). However, PHP1 and PHP2 bound to fibrils
formed by mHTTx1 and DN constructs (Fig. 3B, left two panels,
brackets). Agarose-SDS gel analysis, which is useful for resolv-
ing various assemblies of mHTTx1 (6), revealed that PHP1 and
PHP2 bind to a heterogeneous mixture of mHTTx1 and DN-
mHTTx1 assemblies (Fig. 3C). PHP3 and PHP4 only reacted with
monomeric soluble DN mHTTx1 (Fig. 3B, right two panels, aster-
isks). The enhanced binding of PHP3 and PHP4 to the DN con-
struct of mHTTx1 suggests that removal of N17 domain may
stabilize or better expose the conformations detected by these
antibodies. The low concentration of monomeric mHTTx1 due
to rapid aggregation may also be responsible for the low reactiv-
ity of PHP1–4 in the HEK-293 cell lysates. Similar to PHP1 and
PHP2, MW8 also reacted with mHTTx1 assemblies in HEK-293
cell lysates further suggesting the PRD and the epitope at C-ter-
minus of mHTTx1 (the binding site for MW8) are exposed on the
assembled mHTTx1 fibrils (Supplementary Material, Fig. S5A).
PHP1 and PHP2 react with mHTT fibrils in HD mice
To confirm that PHP antibodies recognize mHTT assemblies
in vivo, we examined brain lysates of two HD mouse models by
WB. N-586 HD mice express the 586 N-terminal AAs of mHTT
with 82Qs, which is proteolytically processed to generate
smaller N-terminal fragments (26). PHP1 recognized monomeric
mutant N-586 in brain lysates obtained from 3-month (3m) old
animals, whereas PHP2 displayed weak binding (Fig. 4A, top and
A
B C
Figure 1. PHP1 and PHP2 bind to preformed recombinant mHTTx1. (A) Electron micrographs of unbundled, bundled, Ab-42, and unbundled (all pro) fibrils left to right,
respectively. (B) Soluble recombinant TRX-HTTx1 (46Q), unbundled and bundled fibrils of mHTTx1, as well as Ab fibrils were spotted on nitrocellulose paper and proc-
essed for reactivity to PHP1–4 and OC (specific for Ab-42 fibrils) antibody as a positive control. Fluorescently labeled secondary antibody (IRDye-800 anti-mouse IgG)
was used as secondary antibody. (C) Dot blot of PHP1 and PHP2 binding to unbundled fibrils (5 ng) containing the native PRD or an all pro-PRD (see sequence in
Materials and Methods section) region. Results were reproduced with multiple preparations.
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bottom panels, respectively, arrows). Similar to cell culture
experiments (Fig. 3), PHP1 and PHP2 bound to high-molecular
weight fibrils assembled in the brains of N-586 HD mice (Fig. 4A,
brackets). Notably, mHTT assemblies were minimal in the
3-month-old brain lysates but accumulated as the animals aged
and developed neurological symptoms (Fig. 4A, 3m compared
with 5m and 7m) (26). Surprisingly, MW8 did not react to mHTT
fibrils in the brain lysates of N-586 HD mice, whereas MW7, which
is specific to polyP repeat of HTT (10), recognized high-molecular
weight structures (Supplementary Material, Fig. S5A and B).
Since MW8 binds to the exposed C-terminus of mHTTx1 (2,10), it
is likely the levels of mHTTx1 fibrils that are minimal in the N-586
HD mice. PHP1 and PHP2 reacted with mHTT fibrils in lysates
extracted from the brains of het Q175 HD mice (Supplementary
Material, Fig. S6A and B). In this model, PHP1- and PHP2-reactive
assemblies also accumulated progressively with age, which was
further confirmed by immunoprecipitation from cortical lysates
(Supplementary Material, Fig. S7A). SDS-agarose gel analyses of
brain lysates of het Q175 HD mice also confirmed the binding of
PHP2 antibody to a heterogeneous mixture of mHTT fibrils, which
are more abundant in the 9-month-old cortical lysates
(Supplementary Material, Fig. S7B). Thus, PHP1- and PHP2-reactive
mHTT fibrils accumulate in the brains of symptomatic HD mice
(25,26). Although PHP1 and PHP2 showed some reactivity to the
monomeric N-586 fragments, they did not recognize full-length
mHTT in the brain lysates of het Q175 HD mice on WB (Fig. 4A,
Supplementary Material, Fig. S7A). A likely explanation is that pro-
teolytic cleavage of full-length mHTT may expose or ‘mature’ the
conformations recognized by PHP1 and PHP2 in the PRD.
Alternatively, binding of PHP1 and PHP2 to PRD of HTT may be
influenced by the polyQ length (82Qs versus 175Qs in the animal
models used) or biochemical processing of brain lysates. PHP3 and
Figure 2. PHP1 and PHP2 detect early assemblies of mHTTx1. (A and B) SMC Erenna immunoassays demonstrating capture of misfolded mHTTx1 by PHP1 and PHP2
antibodies over time and detected by the MW8. (C and D) present binding of PHP3 and PHP4 to monomeric soluble MBP-HTTx1 captured by B27, which is lost after initi-
ation of aggregation. S/B ratio was determined by dividing the EP sample values by the EP values from assay buffer.
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PHP4 reacted with N-586 fragment and full-length mHTT
monomer. Cleaved products of soluble mHTT were also detected
by PHP3 and PHP4 (Fig. 4B, top and bottom panels, respectively,
Supplementary Material, Fig. S6C and D). In these experiments,
PHP3 and PHP4 did not recognize the endogenous mouse HTT
suggesting that the conformations may be unique to human
mHTT.
PHP1- and PHP2-reactive mHTT assemblies are present
in various neuronal organelles
We further examined the reactivity of PHP antibodies to
mHTT assemblies in the brain sections of HD mice by immuno-
histochemistry (IHC). Since PHP1 and PHP2 displayed similar
immunostaining pattern, we focused on the characterization of
PHP2 in the het Q175 HD mouse line. PHP2 recognized mHTT
assemblies in the striatum and to a lesser extent in the
cortical layers of 4-month-old (4m) het Q175 HD brains. Similar
to WB results, PHP2-reactive mHTT assemblies were more
abundant in the 9-month old (9m) brain sections when
compared with 4-month old (4m) and were located in the cyto-
plasm, nuclei and neuropils (Fig. 5A, Supplementary Material,
Fig. S8). In the cortical layers of N-586 HD brains, PHP1- and
PHP2-reactive mHTT assemblies were found within cell
bodies but some were also lined-up in neuropils, which did not
overlap with neuronal marker MAPII (Supplementary Material,
Fig. S9). The lined-up arrangement of mHTT fibrils remains to
be investigated.
To better understand the properties of PHP1- and PHP2-
reactive mHTT assemblies, we performed electron microscopic
analysis of brain sections obtained from the striatum of
9-month-old het Q175 HD mice using immunogold labeling.
These studies revealed that PHP1 and PHP2 bind to mHTT as-
semblies associated with myelin sheath (Fig. 6B–E). mHTT
assemblies were found within and on the inner and outer
leaflets of myelin and between axons (Supplementary Material,
Fig. S10). Notably, PHP1 and PHP2 also reacted with mHTT as-
semblies associated with vesicle-like structures; further sup-
porting their association with neuronal membranes (Fig. 6F and
G). These findings do not exclude the presence of PHP-reactive
mHTT assemblies in other neuronal organelles since IHC
showed that they are found in somas and neuropils (Fig. 5,
Supplementary Material, Figs. S8 and S9). However, detection of
PHP-reactive mHTT assemblies in myelin is intriguing and high-
lights the possibility of fibrils disrupting myelination. By IHC we
did not detect any specific reactivity of PHP3 and PHP4 antibod-
ies to mHTT. One possibility is that the epitopes are buried
within soluble mHTT in neurons or masked by other neuronal
Figure 3. PHP antibodies bind to HTTx1 assemblies formed in HEK-293 cells. (A) Schematic depiction of constructs used for transfection in part (B). (B) WB analysis of
lysates from HEK-293 cells transfected with various constructs of HTTx1. Membranes were probed with PHP1–4 antibodies. Asterisks in the left two panels indicate
faint detection of WT HTTx1 (8Q) by PHP1 and PHP2, respectively. Arrows in the left two panels point at weak reactivity of PHP1 and PHP2 to DN-mHTTx1. Brackets indi-
cate the assemblies of mHTTx1 and DN-mHTTx1 detected by PHP1 and PHP2. PHP3 and PHP4 only detected monomeric mHTTx1 highlighted by asterisks in the right-
most two panels, respectively. Part (C) shows examination of HEK-293 cell lysate expressing mHTTx1 and DN-mHTTx1 by agarose-SDS gel electrophoresis and probing
with PHP1 and PHP2. All experiments were repeated three times. N.S., non-specific bands.
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proteins. Some diffused nuclear binding to the brain sections of
het Q175 HD mice was observed under florescent microscope;
however, the authenticity of the binding remains to be investi-
gated considering that the majority of monomeric mHTT is
localized to the cytoplasm.
PHP antibodies block the fibril assembly and seeding of
mHTTx1
To better understand the influence of QAQPLLPQP and
QQQQQQPP epitopes on mHTTx1 folding and assembly, we ap-
plied electron paramagnetic resonance (EPR) to examine the ag-
gregation of mHTT in the presence of each antibody. EPR
combined with site-directed spin labeling can monitor the mo-
bility of spin-labeled AA. EPR can be used to follow the fibril for-
mation of amyloidogenic proteins over time since the mobility
decreases severely as the intrinsically disordered monomers as-
semble into fibrils (27). To initiate fibril assembly, soluble re-
combinant thioredoxin-mHTTx1 [TRX-mHTTx1 (46Q)] protein
labeled with spin label R1 at position 15, was treated with en-
terokinase to remove the TRX fusion partner. Aggregation of
mHTTx1 decreased spin label mobility and thus reduced the
EPR signal amplitudes over a period of 15 h (Fig. 7A). When PHP
antibodies (PHP1–4) were included in the fibril assembly assays,
the reduction of the EPR amplitudes was significantly attenu-
ated in a concentration-dependent manner indicating that the
antibodies inhibited fibril formation (Fig. 7B). PHP1 and PHP2
were able to bind to fibrillar species (Figs 1, 3 and 4) and thus, it
is possible that some of these species facilitate seeding. To test
whether these antibodies can act on seeds, we investigated
seeding-dependent aggregation using sonicated preformed
fibrils in the presence of PHP2. In the absence of PHP2, seeds
strongly enhanced misfolding as monitored by EPR (Fig. 7C),
whereas the addition of PHP2 completely inhibited seeding.
PHP3 and PHP4, which do not preferentially recognize fibrillar
species, exhibited only marginal inhibitory activity towards the
seeded reaction compared to the unseeded one (Fig. 7D).
Some assemblies of mHTT are present in the cerebrospinal
fluids of HD patients, which promote seeding of monomeric
mHTTx1 in vitro and in cell models (28,29). We asked whether
PHP1 and PHP2 antibodies decrease seeding of mHTTx1 in a cell
culture model (29). Cell lysates containing mHTTx1–73Q fibrils
(Fig. 3C) were added to HEK-293 cells expressing subthreshold
levels of mHTTx1-EGFP (103Q) with minimal aggregation. We
found that treatment of cells expressing mHTTx1-EGFP with the
lysates containing mHTTx1–73Q assemblies accelerates the ag-
gregation of intracellular mHTTx1-EGFP (Fig. 8A and B). To con-
firm that PHP1 and PHP2-reactive mHTTx1 structures are
indeed responsible for the seeding effects, we preincubated the
seeding lysates with several antibodies such as polyQ-specific
MW6, which recognizes soluble mHTT, MW8 specific for the
C-terminus of mHTTx1, and PHP1 or PHP2. Preincubation with
MW6 or MW8 had no effects, whereas addition of PHP1 or
PHP2 antibodies to the seeding lysates significantly reduced the
assembly of mHTTx1-EGFP fibrils (Fig. 8A and B). Thus, PHP1
and PHP2 bind to mHTTx1 species, which may have the propen-
sity for cell-to-cell transmission and the ability to induce
seeding.
Figure 4. PHP antibodies bind to mHTT assemblies in the brains of HD mice. (A) WB analysis of cortical lysates of N-586 HD mice harvested at 3, 5 and 7 months (m) of
age and probed with PHP1 and PHP2 (top and bottom panels, respectively). Cortical lysates of 3-month-old WT mice were used as controls. Arrows point to monomeric
N-586 (82Q) detected by each antibody. Brackets are the mHTT assemblies present in the brain lysate of 5-month and 7-month-old N-586 HD mice, which are less abun-
dant in the 3-month olds. Part (B) is WB analysis of the same lysates probed by PHP3 and PHP4. Both antibodies react with monomeric N-586 fragment and some
smaller products highlighted by asterisks. N.S., non-specific bands. The house keeping protein glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a
loading control. Lysates obtained from brains of offspring from various cohorts revealed similar results.
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Figure 5. PHP2-reactive assemblies accumulate in the striatum and cortical layers. (A) Low magnification of a composite demonstrating the reactivity of PHP2 to mHTT
assemblies in the brain sections (striatum and cortical layers) of 4-month (4m) and 9-month (9m) old het Q175 HD mice. The neuronal marker NeuN (green) was used
to stain neurons. PHP2 staining of assemblies is in red. Black and white panels for the PHP2 staining is shown to demonstrate the intensity of staining for PHP2 masked
by the NeuN staining. Images were captured by a confocal microscope (Zeiss LSM 710). IHC results were reproduced with offspring from various cohorts. CTX, cortex;
STR, striatum.
Figure 6. PHP-1 and PHP2-reactive mHTT assemblies associate with myelin. (A) Electron micrograph of brain sections of 9-month-old het Q175 HD mice showing the
presence of PHP1 and PHP2 reactive fibrils in the myelin sheath. Panels (A)–(C) are projection images and panels (D) and (E) are tomograms. Panels (F) and (G) show the
association of PHP1 and PHP2-reactive fibrils with vesicle-like structures. EM studies were reproduced with sections obtained from the brain of several het Q175 HD
mice.
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Figure 7. Monitoring mHTTx1 misfolding and inhibition by PHP antibodies using EPR. (A) Continuous wave EPR spectra of mHTTx1 spin labeled at position 15 obtained
at the indicated time points. Misfolding causes line broadening and a concomitant reduction in amplitude. (B) Summary of EPR amplitudes of the same spin-labeled de-
rivative used in (A) after 15 h of incubation in the absence (no Ab) or presence of controls or PHP1–4 antibodies with the indicated concentrations. The addition of
PHP1–4 results in a dose-dependent protection from signal loss due to misfolding. The control Abs (C-Ab1 and C-Ab2, not against HTT 1 mg/ml) and control protein
(BSA, 1 mg/ml) did not affect mHTTx1 misfolding significantly. Panel (C) illustrates the effect of seeded misfolding in the presence (black bars) or absence (gray bars) of
PHP2 antibody at 1 mg/ml at the indicated time points. The white bars (no Ab, no seed) are the control which did not contain added seeds and antibodies.
(D) Comparison of EPR amplitude of the unseeded (gray bar) and seeded (black bar) reaction for mHTTx1 misfolding after 15 h in the presence of PHP2–4 antibodies.
PHP2 significantly inhibits the seeded reaction, whereas the inhibitory effects of PHP3 and PHP4 were marginal. The error bar represents the standard deviation of the
mean from the three individual measurements. (ns, P> 0.05; *, P0.05; **, P0.01; ***, P0.001).
Figure 8. Cell-based assays examining the effects of PHP1 and PHP2 on seeding of mHTTx1. (A) Fifty lg of lysates obtained from HEK-293 transfected with mHTTx1
(Q73) (Fig. 3B) were treated with DNase and RNase (1 lg each) and added to HEK-293 cells in six well dishes transfected with subthreshold level of mHTTx1-EGFP (0.2 lg
plasmid DNA) to reduce spontaneous aggregation. For antibody interference, lysate was preincubated with each indicated antibody for 2 h rocking at RT and then
added to cells. Plates were examined 12 h after treatment. Random pictures were taken at low magnification and quantified for aggregated bodies in each frame. All
experiments were repeated three times. (B) The average of six microscope fields for each condition is presented in (C). Data shown are means 6 SD. **P<0.001.
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Discussion
The N-terminal fragments of mHTT are predicted to acquire a
spectrum of conformations as it misfolds and assembles into
oligomers, fibrils and inclusion bodies (6–8,30). Distinguishing
between different assemblies of mHTT in vivo is critical for
studying their biological properties and ultimately identifying
the elusive neurotoxic species. Using PHP1 and PHP2 mAbs, we
detected epitopes within the PRD of mHTT fibrils in vitro and in
cellular and mouse models of HD. Moreover, the PHP-reactive
fibrils accumulate in various neuronal organelles including my-
elin and vesicle-like structures. PHP3 and PHP4 mAbs recog-
nized novel epitopes formed at the border of polyQ-polyP in
monomeric full-length and N-terminal fragments of mHTT. The
newly discovered motifs recognized by PHP1–4 play a role in the
fibril assembly and seeding of amyloidogenic N-terminal frag-
ments of mHTT. These findings and the generated mAbs will
help to better understand the epitopes involved in the assembly
of mHTT fibrils and may lead to identifying unique structures
linked to specific cellular compartments with novel pathological
phenotypes.
We previously reported that the PRD of mHTT serves several
biological functions such as regulating protein stability,
aggregation and neurotoxicity (31,32). Recent studies suggest
that PRD contributes to the heterogeneity of mHTTx1 assem-
blies, raising the possibility that the impact of PRD on the bio-
logical and pathological activities of mHTTx1 may be mediated
by conformations evolved during misfolding and aggregation
process (14,15). Here we identified PHP1- and PHP2-reactive epit-
opes within the PRD, which may biologically be important.
Based on differences in the AA sequence of the antigenic bind-
ing domains of each antibody (VH and VL), we envision that
PHP1 and PHP2 may recognize distinct but overlapping anti-
genic motifs, which are exposed in the assembled mHTT fibrils.
However, our assays lack the sensitivity to determine the
unique properties or each antibody and remains to be investi-
gated. It is likely that mHTT fibrils detected by PHP1 and PHP2
are heterogeneous (Figs 1–4). Heterogeneity in amyloidogenic
proteins such as Ab are linked to distinct clinical phenotypes in
Alzheimer’s disease (AD) (33). Structural diversity in fibrils also
contributes to distinct biological and pathological functions in
Tau and a-synuclein proteins implicated in Taupathies and
Parkinson’s disease (PD), respectively (34,35). We predict that
the intrinsically disordered N-terminal fragments of mHTT may
also assemble into a spectrum of structures and those identified
by PHP1 and PHP2 may represent only a fraction of all misfolded
mHTT. Supporting this hypothesis is the reactivity of PHP1 and
PHP2 but not MW8 to mHTT fibrils in N-586 HD mice, whereas
all three antibodies recognize mHTTx1 assemblies in cell cul-
ture (Figs 3 and 4, and Supplementary Material, Fig. S5). To ex-
pand on this hypothesis, it is essential to develop a repertoire of
oligomeric- and fibril-specific antibodies and identify mHTT as-
semblies that are different from those detected by PHP1 and
PHP2 in vivo. Such studies are in progress and will facilitate in-
vestigating the biological and pathological functions of various
assembled structures of mHTT.
Age-dependent accumulation of PHP1- and PHP2-reactive
mHTT fibrils in HD mouse models and overlap with neurological
symptoms supports the notion that such structures may patho-
logically be relevant. The interaction of mHTT with cellular
organelles including nuclei, mitochondria and other membra-
nous structures may disrupt neuronal physiology, impair organ-
elles’ architectures and disrupt neuroprotective pathways (3). A
novelty of the current studies was discovering the association
of PHP1- and PHP2-reactive mHTT assemblies within myelin
sheath and membranous-like vesicles in the brains of HD ani-
mals (Fig. 6, and Supplementary Material, Fig. S10). Recent stud-
ies indicate that fibrils of mHTTx1-GFP interact with the
membranes of endoplasmic reticulum causing architectural de-
formities and toxicity (36). We speculate that the presence of
PHP1- and PHP2-reactive mHTT in myelin sheath may promote
axonal defects and/or impair the physiology of oligodendro-
cytes. Mice expressing mHTT exclusively in oligodendrocyte
show deficit in myelin formation and animals develop severe
neurological symptoms with accelerated death (37). Moreover,
myelin defects precede the appearance of aberrant cognitive
and motor symptoms in HD mouse models and in HD patients
(3,38,39). Although it remains to be confirmed, mHTT aggregates
are less abundant in oligodendrocytes when compared with
neurons (38). We predict that PHP1- and PHP2-reactive mHTT
assemblies in myelin sheath are of neuronal origin and high-
light the interesting possibility of impairing oligodendrocytes’
functions non-cell-autonomously.
The interaction of PHP1- and PHP2-reactive assemblies with
membranes may also facilitate their transport to neighboring
cells and contribute to the propagation of mHTT in the CNS.
mHTT is released into intercellular space through endosomal/
lysosomal secretory vesicles (40). Moreover, assemblies of
mHTTx1 are transported along the axons of primary neurons
and secreted into culture medium (41). It is likely that not all as-
semblies of mHTT are capable of associating with membranes
or being transported to other cells. Notably, PHP1 and PHP2
antibodies block seeding of mHTTx1 in vitro and in a cell model
(Figs 7 and 8); further suggesting the propensity of such struc-
tures for intercellular spread and propagation. The mechanism
of how PHP-reactive assemblies associate with myelin and
vesicle-like structures remains to be investigated. However, it is
known that the N17 domain of monomeric HTT interacts with
membranes in vitro and influences aggregation and toxicity in
cell models (42–44). Thus, it may be that the assembly of PHP1-
and PHP2-reactive fibrils is regulated by membranes.
Alternatively, preformed PHP1- and PHP2-reactive fibrils of
mHTT may directly bind to membranes (45). Insertion in mem-
branes and myelin may also stabilize mHTT fibrils by physical
constraints thus, impeding the formation of bundled fibrils and
inclusion bodies. Overall, mHTT assemblies identified by PHP1
and PHP2 mAbs exemplify viable biomarkers for exploring vari-
ous aspects of HD pathogenesis including neurotoxicity, path-
ways for spreading within the CNS, as well as myelin and
oligodendrocytes impairments. Experiments are in progress to
examine these and to further determine whether the interac-
tion of PHP-reactive fibrils with myelin precedes the develop-
ment of motor behaviors in animal models.
The binding of PHP3 and PHP4 to epitopes formed by the
polyQ-polyP junction further adds to repertoire of novel confor-
mations formed by the mHTTx1. Little is known about the inter-
actions of polyQ with polyP domains and how they may
influence the misfolding of mHTTx1. Thus, PHP3 and PHP4
mAbs are useful reagents to perform structure–function analy-
ses and further dissect the involvement of structures formed by
polyQ-polyP junction in the biology of mHTT. It is relevant that
binding of PHP3 and PHP4 to monomeric mHTTx1 diminishes as
the fibrils assemble (Fig. 2). One possibility is that conforma-
tions formed by the combination of polyQ and polyP repeats are
dynamic and disappear as the mHTTx1 misfolds and ensues ag-
gregation. Alternatively, such conformations could be buried
within the fibrils and are less accessible to binding.
Interestingly, PHP3 and PHP4 block the fibril assembly of
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mHTTx1 in vitro highlighting a potential role for polyQ/polyP
junction in the biogenesis of mHTT assemblies and further sup-
porting that multiple epitopes downstream of the polyQ domain
are critical for the biogenesis of misfolded mHTT structures
(6,14,15).
In summary, we have identified new antigenic motifs linked
to monomers and fibril assemblies of mHTT. The application of
PHP1–4 antibodies to monitor the fibril assembly of mHTT and
to enrich for assemblies from various sources will help to better
understand their properties and to identify structures, which
may influence neurotoxicity in HD. Considering the recent find-
ings on the release of mHTT assemblies in biological fluids of
HD patients and the ability to spread by a ‘prion-like’ mecha-
nism (28,29,46), testing of PHP antibodies as immunotherapies
to interfere with seeding and/or spreading of mHTT structures
within the CNS and developing assays to screen for small mole-




The N-586 (82Q) breeding pairs were provided by Dr Christopher
Ross, and heterozygous (het) Q7/Q175 knock-in HD mouse
brains were obtained from the Jackson Laboratory. All mice
experiments and care complied with federal regulations and
were reviewed and approved by the California Institute of
Technology Institutional Animal Care and Use Committee
(IACUC).
Immunization and antibody production
Immunization and hybridoma production was carried out as de-
scribed previously (10). Recombinant purified WT HTTx1 (20Q)
fused to glutathione S transferase (GST) was used as an antigen.
Initially clones were screened based on reactivity to lysates
obtained from HEK-293 cells expressing various constructs of
HTT by WB analysis. Four reactive clones described here were
labeled as PHP1–4 in honor of the late professor Paul H.
Patterson.
Antibodies
2B7, MW6 and MW8 antibodies have been reported previously
(10,23). MAPII was purchased from ThermoFisher and rabbit
anti-NeuN (ABN78) was obtained from EMD Millipore.
Epitope mapping
To determine the epitopes recognized by the new mAbs, we uti-
lized arrays of dot blots that contain overlapping 14mer pepti-
des synthesized from the first 91 AA of normal human
Huntingtin (HTT; containing a 23 polyQ domain) (10). That is,
the first dot contains the peptide corresponding to AA 1–14, the
second dot contains the peptide corresponding to 4–17, etc. Two
rows of peptide dot blots are shown for each with the upper row
corresponding to the peptides shown at the top of the figure,
and the lower row corresponding to the peptides shown at the
bottom of the array in Supplementary Material, Figure S1. Also,
included in the array are corresponding peptides from the
mouse HTT sequence in order to confirm that binding of anti-
bodies is unique to human HTT (spot #27–32). The mouse
peptides are shown at the bottom right of Supplementary
Material, Figure S1.
Purification of fusion protein HTTx1
The fusion protein human HTTx1 was expressed and purified as
described previously (14,27). Briefly, the overnight cultures
of pET32a-HTTx1 (46Q) transformed BL21 cells were grown to
A600 nm ¼ 0.7–0.8 at a dilution of 50 folds in Lauria Broth (LB) me-
dium and further grown at 37C. The expression was achieved
using IPTG and subsequent purification was done using affinity
chromatography followed by ion exchange chromatography.
Fibril formation
Unbundled fibrils were prepared by cleaving the TRX-mHTTx1
(46Q) fusion protein using 1 unit of EKmax per 280 mg of HTT.
The protein concentration was kept at 25 lM in 20 mM Tris, 150
mM Nacl pH 7.4 buffer. Prior to cleavage reaction the samples
were treated with 5% molar ratio HTTx1 (Q46) seeds. The final
reaction mixture was incubated at 4C for 2 days. The bundled
fibrils were prepared in a similar manner, except the pre-seeded
samples were incubated at 37C for several days until bundled
fibrils were observed.
Proline C-terminus fibrils
The plasmids were reconstructed from parent construct to
make all proline C-terminus HTTx1 by GenScript. Primary se-
quence of the modified poly PRD HTTx1 is listed: MATLEKLMKA
FESLKSF (Q)46-P(38) GGAVAEEGL HRGHHHHHH. The expression
and purification of the fusion protein was achieved using previ-
ously reported methods (27). The fibril formation was induced
similarly, using EK max digestion. The final protein concentra-
tion in the fibrils was estimated using spin-labeled derivative.
Ab42 fibrils
Ab42 fibrils were prepared using a standard protocol (47).
Briefly, the lyophilized peptide was dissolved in DMSO at a con-
centration of 5 mM. The aliquots were then transferred to 10
mM HCl to a final concentration of 100 mM peptide. The samples
were incubated for 24 h at 37C.
Dot blots
A total of 1.5 ml of desired samples were blotted onto nitrocellu-
lose membrane (VWR) and incubated with desired primary anti-
body at 1–500 dilutions. Fluorescently labeled secondary
antibody (IRDye-800 anti-Mouse IgG, 1: 10 000 dilution; LI-COR)
was used to visualize binding via a LI-COR Odyssey Infrared
Imaging system.
Huntingtin protein aggregation
To perform aggregation kinetics, 10 mM MBP-tagged HTT exon1-
Q46 were mixed with 150 mg/ml bovine thrombin protease
(Sigma) and 2 mM CaCl2 in a total volume of 1400 ml 50 mM Tris
(pH 8.0), 150 mM NaCl. Samples were incubated for 24 h at 37C.
Aliquots were analyzed before and at multiple time points after
initiation of aggregation by protease addition. Samples were im-
mediately snap-frozen at each time point and stored at 20C.
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Huntingtin protein detection assay
Huntingtin protein was detected by the SMC Erenna immunoas-
say system by Singulex (now EMD Millipore) using the previ-
ously described protocol (23) with the following modifications.
In short, samples were diluted into dilution buffer containing
6% BSA, 0.8% Triton X-100, 750 mM NaCl. Samples were added
to a 96-conical assay plate (catalog P-96-450V-C; Axygen).
Capture antibodies (2B7, MW8 or PHP1-4) coupled to magnetic
particles was added, and the plate was sealed and incubated
under shaking at room temperature for the indicated time
points. After washing, the fluorophore-labeled detection anti-
bodies (MW8 or PHP1-4) was added to the plate and incubated at
room temperature for 1 h. Plates were washed, and the
antibody-antigen complex was transferred to a new 96-conical
assay plate to eliminate non-specific binding events to the plas-
tic. After washing, elution buffer and the eluted detection anti-
body was transferred to a Nunc 384-well analysis plate (catalog
264573; Sigma-Aldrich) and neutralized with buffer (1 M Tris, pH
9). The analysis plate was spun down to eliminate foaming and
bubble formation, sealed and subsequently analyzed with the
SMC Erenna immunoassays. Event photons (EP) values were
taken as absolute signal intensity values. Signal-to-background
(S/B) ratio was determined by dividing the EP sample values by
the EP values from assay buffer.
Transfections
HEK-293 cells were transfected with the indicated constructs in
Figure 3A (6) by calcium phosphate precipitation. Cells were
harvested 36 h post-transfection, lysed in RIPA buffer (50 mM
Tris, 150 mM NaCl, 1% sodium deoxycholate, 1%SDS, 1%NP40,
2m MEDTA, pH 7.4 with protease inhibitor cocktail) (Roche) and
examined by SDS-PAGE and WB analysis using PHP antibodies
as the primary. All HRP-conjugated secondary antibodies were
used at 1: 10 000 dilutions.
Western blots of brain lysates
Flash frozen cortical and striatal brain tissues were collected as
follows: brains free from skull were immersed in cold PBS briefly
and placed in dish on top of ice pack for dissection. Under dis-
section microscope with ventral side up two coronal cuts were
made, one cut to remove olfactory bulbs, the other cut at optical
chiasm. Separate cortex and striatum, collect them in
Eppendorf tubes, flash frozen in liquid nitrogen and store in
80C until ready to use. Cortical or striatal tissues were
extracted with total extraction buffer: RIPA buffer and sonicated
briefly before centrifugation at 14 300 rpm at 4C for 30 min
using tabletop centrifuge. Protein fractions were run with either
4–15% or –20% polyacrylamide Criterion gels (Bio-Rad
Laboratories) and transferred overnight, blots were blocked
with 5% milk in PBS and blotted with PHP (1: 1000) Abs over-
night. Blots incubated with HRP-conjugated goat anti-mouse
secondary Ab and developed with ECL substrate (ThermoFisher,
SuperSignal West Dura substrate 34705) and X-ray film. Agarose
gel electrophoresis of samples to confirm the heterogeneous
nature of reactive products was carried out as described previ-
ously (6,48).
Cryosections and immunohistochemistry
WT and HD mice were perfused with PBS followed by 4% para-
formaldehyde and processed for cryosectioning by standard
procedures as described previously (10). Frozen 18 um thick
brain sections were obtained using cryostat (Leica CM3050) and
mounted onto slides (Fisher Superfrost Plus), were dried over-
night and stored slides at 20C. Slides were thawed and dried
and washed in PBS briefly before antigen retrieval. Sections
were immersed in antigen retrieval solution (Dako Target re-
trieval solution, S1699) inside a plastic slide-staining dish
(Tissue Tek) and incubated at 95C water bath for 25 min. Slides
were cooled in a dish and washed in PBS before applying pri-
mary antibodies. Primary Abs were diluted in 2% BSA, 10% nor-
mal goat serum in PBS with 0.4% Triton X-100. Sections were
incubated with primary Abs at room temperature overnight.
Slides were then washed with PBS, three times, 10 min each, be-
fore adding secondary Abs. After 1 h of incubation, sections
were then washed and mounted with mounting medium
(ThermoFisher, prolong gold antifade mounting solution).
Sections were observed under epi-fluorescence (Nikon Diaphot
300) or a confocal microscope (Zeiss LSM 710).
Electron microscopy of mHTTx1 and Ab fibrils
A total of 10 ml of preformed fibril sample was absorbed onto EM
grid (150 mesh copper) for 5 min. Grids were then negatively
stained by adding 10 ll of 1% uranyl acetate solution for 12 min
and dried at room temperature. Images were acquired using a
Gatan digital camera equipped with a JOEL JEM-1400 electron
microscope (JOEL, Peabody, MA) at 100 kV.
Immuno-electron microscopy
Brain tissue was and fixed with 4% paraformaldehyde (PFA) in
PBS. Tissue was excised and infiltrated with 2.1 M sucrose in 0.1
M sodium cacodylate trihydrate for 12 h. Small (1 mm3) cubes of
tissue were prepared with a scalpel, affixed to aluminum sec-
tioning stubs and frozen quickly in liquid nitrogen. Frozen
specimens were placed in the cryostage of a UC6/FC6 cryoultra-
microtome (Leica Microsystems, Vienna) set to 110C. Thin
(100 nm) cryosections were cut using a diamond knife (Diatome
Ltd., Switzerland) and transferred to Formvar-coated, carbon-
stabilized 100-mesh copper-rhodium EM grids (Electron
Microscopy Sciences, Port Washington PA). The sections were
blocked with 10% calf serum in PBS for 30 min, then labeled
with PHP1, PHP2 diluted in PBS with 5% calf serum for 2 h, fol-
lowed by colloidal gold (15 nm) conjugated anti-mouse second-
ary antibodies (BBI Solutions, Cardiff UK) for 2 h. Sections were
simultaneously negative-stained with 1% uranyl acetate and
embedded with 1% methylcellulose, then air-dried in wire
loops.
Grids were placed in a dual-axis tomography specimen
holder (Model 2040, E.A. Fischione Instruments, Inc. Export PA)
and imaged with a Tecnai TF30ST transmission electron micro-
scope (ThermoFisher Scientific, Hillsboro OR) at 300 keV. Images
were recorded digitally with a US1000 CCD camera (Gatan, Inc.
Pleasanton CA) using the Serial EM software package (49).
Digital images, montages and tomographic datasets were calcu-
lated and analyzed with the IMOD software package (50,51).
Effect of antibodies on misfolding of HTTx1: EPR study
The Trx-mHTTx1 (46Q) fusion protein harboring a cys residue at
position 15 was reacted with MTSL spin label to yield the new
spin-labeled side chain R1 as described in previous publications
(27). The concentration of the spin-labeled protein was 15 uM
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in 20 mM Tris, 150 mM Nacl pH 7.4 buffer. Misfolding of
mHTTx1 was initiated by the addition of Ekmax (Invitrogen),
which cleaves off the stabilizing TRX moiety, as described in the
fibril preparation section. The continuous wave EPR spectra
were recorded using a Bruker EMX EPR spectrometer at 100 G
and optimized power and modulation settings as in previous
publications (14,27). Control experiments showed that Ekmax
cleavage was not affected by antibodies.
Cell lysate seeding assays
HEK-293 cells were transfected with mHTTx1-EGFP (103Q) in 6-
well plates at subthreshold concentration (0.2 lg of plasmid DNA)
for spontaneous aggregation using Lipofectamine (Thermo Fisher
Scientific, Carlsbad, CA). Twelve h post transfection, cells were
treated with 50 lg of DNase/RNAse-treated lysates obtained from
HEK-293 cells expressing mHTTx1 (73Qs) (Fig. 3B) and incubated
for additional 12 h. For testing the effects of antibodies on seed-
ing, 50 lg of lysate containing the seeding material was prec-in-
cubated with 5 lg of each antibody and rocked at RT for 2
h before addition to target cells expressing mHTTx1-EGFP (103Q).
Samples were examined by a Nikon florescent microscope and
images were captured. The number of inclusion foci were
counted in six microscope fields for each condition and averaged.
Supplementary Material
Supplementary Material is available at HMG online.
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